• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic polymorphisms in Parkinson's disease.

作者信息

Checkoway H, Farin F M, Costa-Mallen P, Kirchner S C, Costa L G

机构信息

University of Washington, Department of Environmental Health, Seattle 98195-7234, USA.

出版信息

Neurotoxicology. 1998 Aug-Oct;19(4-5):635-43.

PMID:9745923
Abstract

The search for genetic polymorphisms relevant to Parkinson's disease etiology and pathogenesis has been motivated by recent thinking emphasizing the potential significance of gene-environment interactions. Especially influential to this research have been the MPTP model of PD induction, hypotheses concerning oxidative stressor reactions, and epidemiological observations of an inverse relation between cigarette smoking and PD risk. This brief review summarizes trends in genetic polymorphism research, with examples provided by investigations of cytochrome P450 enzymes, monoamine oxidase, superoxide dismutase, and mitochondrial genes.

摘要

相似文献

1
Genetic polymorphisms in Parkinson's disease.
Neurotoxicology. 1998 Aug-Oct;19(4-5):635-43.
2
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.帕金森病中的基因-环境相互作用。CYP2D6基因多态性情况。
Adv Neurol. 1996;69:61-72.
3
P450 enzymes and Parkinson's disease: the story so far.细胞色素P450酶与帕金森病:迄今为止的情况
Mov Disord. 1998 Mar;13(2):212-20. doi: 10.1002/mds.870130204.
4
DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.帕金森病患者及非相关对照者单胺氧化酶B基因编码区和启动子区的DNA序列分析
Mov Disord. 2004 Jan;19(1):76-83. doi: 10.1002/mds.10624.
5
Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.帕金森病中谷胱甘肽S-转移酶M1、P1、T1和Z1基因多态性与吸烟相互作用的病例对照研究
Neurosci Lett. 2004 Aug 19;366(3):326-31. doi: 10.1016/j.neulet.2004.05.061.
6
Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease.锰超氧化物歧化酶 Val-9Ala 和 Ile+58Thr 多态性与帕金森病。
Clin Biochem. 2010 Aug;43(12):979-82. doi: 10.1016/j.clinbiochem.2010.05.009. Epub 2010 May 24.
7
[Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].[细胞色素P-450酶基因多态性与帕金森病之间的关联]
Zhonghua Yi Xue Za Zhi. 2000 Aug;80(8):585-7.
8
Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population.西班牙人群中线粒体DNA多态性与帕金森病风险
J Neurol Sci. 2005 Sep 15;236(1-2):49-54. doi: 10.1016/j.jns.2005.04.016.
9
No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes.帕金森病与内皮型一氧化氮合酶(eNOS)、神经元型一氧化氮合酶(nNOS)和诱导型一氧化氮合酶(iNOS)基因的三种多态性之间无关联。
Neurosci Lett. 2007 Feb 21;413(3):202-5. doi: 10.1016/j.neulet.2006.11.044. Epub 2006 Dec 15.
10
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.单胺氧化酶B(MAOB)和儿茶酚-O-甲基转移酶(COMT)基因多态性对散发性帕金森病患者左旋多巴治疗的影响。
Acta Neurol Scand. 2004 Oct;110(4):260-6. doi: 10.1111/j.1600-0404.2004.00315.x.

引用本文的文献

1
Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.特发性帕金森病患者血小板单胺氧化酶-B活性的改变
Neurochem Res. 2009 Aug;34(8):1427-32. doi: 10.1007/s11064-009-9929-4. Epub 2009 Mar 4.
2
Geographic model and biomarker-derived measures of pesticide exposure and Parkinson's disease.农药暴露与帕金森病的地理模型及生物标志物衍生指标
Ann N Y Acad Sci. 2006 Sep;1076:378-87. doi: 10.1196/annals.1371.074.
3
Lack of the DNA repair enzyme OGG1 sensitizes dopamine neurons to manganese toxicity during development.
DNA修复酶OGG1的缺失使发育过程中的多巴胺神经元对锰毒性敏感。
Gene Expr. 2005;12(4-6):315-23. doi: 10.3727/000000005783992007.
4
Neurodegenerative diseases: an overview of environmental risk factors.神经退行性疾病:环境风险因素概述
Environ Health Perspect. 2005 Sep;113(9):1250-6. doi: 10.1289/ehp.7567.
5
Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.脑内细胞色素P450在临床药代动力学中的潜在作用:内源性化合物的调节作用
Clin Pharmacokinet. 2004;43(11):693-706. doi: 10.2165/00003088-200443110-00001.
6
Perspectives on MAO-B in aging and neurological disease: where do we go from here?衰老与神经疾病中MAO-B的研究展望:我们将何去何从?
Mol Neurobiol. 2004 Aug;30(1):77-89. doi: 10.1385/MN:30:1:077.
7
Chromosomal loci influencing the susceptibility to the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.影响对帕金森病神经毒素1-甲基-4-苯基-1,2,3,6-四氢吡啶易感性的染色体位点。
J Neurosci. 2003 Sep 10;23(23):8247-53. doi: 10.1523/JNEUROSCI.23-23-08247.2003.
8
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.蛋白质聚集与聚集体毒性:对蛋白质折叠、错误折叠疾病及生物进化的新见解。
J Mol Med (Berl). 2003 Nov;81(11):678-99. doi: 10.1007/s00109-003-0464-5. Epub 2003 Aug 27.
9
Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus.锰超氧化物歧化酶和细胞外超氧化物歧化酶基因多态性及其与1型糖尿病患者糖尿病神经病变的关系。
BMC Med Genet. 2001;2:4. doi: 10.1186/1471-2350-2-4. Epub 2001 Mar 28.
10
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.二肽基羧肽酶1(DCP1)和丁酰胆碱酯酶(BCHE)基因与载脂蛋白Eε4等位基因的相互作用,作为阿尔茨海默病以及伴有阿尔茨海默病理共存的帕金森病的风险因素。
J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766.